AU2003294100A1 - Use of hyaluronic acid for respiratory disorders or the upper airways - Google Patents

Use of hyaluronic acid for respiratory disorders or the upper airways

Info

Publication number: AU2003294100A1
Authority: AU; Australia
Prior art keywords: hyaluronic acid; respiratory disorders; upper airways; airways; respiratory
Prior art date: 2002-11-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003294100A

Other versions

AU2003294100A8 (en

Inventor

Anthony Bresin

Martine Briet

Regis De Baynast

Franck Launay

Edith Puchelle

Beatrice Raby

Jean-Marie Zahm

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Institut National de la Sante et de la Recherche Medicale INSERM

Agro Industrie Recherches et Developpements ARD

Original Assignee

Agro Industrie Recherches et Developpements ARD

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-28

Filing date

2003-11-27

Publication date

2004-06-23

2003-11-27 Application filed by Agro Industrie Recherches et Developpements ARD filed Critical Agro Industrie Recherches et Developpements ARD

2004-06-23 Publication of AU2003294100A1 publication Critical patent/AU2003294100A1/en

2004-06-23 Publication of AU2003294100A8 publication Critical patent/AU2003294100A8/en

Status Abandoned legal-status Critical Current

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
208000023504 respiratory system disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AU2003294100A 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways Abandoned AU2003294100A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0214979A FR2847818B1 (en)	2002-11-28	2002-11-28	PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID
FR02/14979		2002-11-28
PCT/FR2003/003507 WO2004050187A1 (en)	2002-11-28	2003-11-27	Use of hyaluronic acid for respiratory disorders or the upper airways

Publications (2)

Publication Number	Publication Date
AU2003294100A1 true AU2003294100A1 (en)	2004-06-23
AU2003294100A8 AU2003294100A8 (en)	2004-06-23

Family

ID=32309802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003294100A Abandoned AU2003294100A1 (en)	2002-11-28	2003-11-27	Use of hyaluronic acid for respiratory disorders or the upper airways

Country Status (3)

Country	Link
AU (1)	AU2003294100A1 (en)
FR (1)	FR2847818B1 (en)
WO (1)	WO2004050187A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060183709A1 (en) *	2005-02-15	2006-08-17	Ahmad Alkayali	Preparation of low molecular weight hyaluronic acid as a food supplement
ITMI20060742A1 (en)	2006-04-13	2007-10-14	Patrizia Pattini	ANTIBACTERIAL COMPOSITIONS FOR TREATMENT OF INFECTION OF HIGH AND LOW AIRCRAFT
FR2919185B1 (en) *	2007-07-23	2010-09-10	Ard Sa	USE OF HYALURONIC ACID FOR THE PREPARATION OF COMPOSITIONS INTENDED TO IMPROVE THE CONDITION OF MUCOUS MEMBRANES
IT1396468B1 (en) *	2008-11-11	2012-12-14	Farma Derma Srl	TOPIC USE OF HYALURONIC ACID FOR FILMOGEN ACTION IN PREPARATIONS FOR TREATMENT AND PROPHYLAXIS OF PATHOLOGIES OF THE RESPIRATORY PATHWAYS.
EP2985027B1 (en)	2014-08-16	2021-03-31	Church & Dwight Co., Inc.	Nasal composition comprising mixture of hyaluronic acids and saline solution
EP2985019B1 (en)	2014-08-16	2021-10-20	Church & Dwight Co., Inc.	Nasal composition having anti-viral properties
EP3415154A1 (en)	2017-06-16	2018-12-19	Sofibel S.A.S.	Nasal composition
JP2024540319A (en)	2021-11-05	2024-10-31	アンスティチュナショナルドゥラサンテエドゥラルシェルシュメディカル	Use of low molecular weight hyaluronic acid for the treatment of pulmonary mucosal inflammation
WO2024194437A1 (en)	2023-03-22	2024-09-26	Institut National de la Santé et de la Recherche Médicale	Use of low molecular weight hyaluronic acid for promoting ciliated cell differentiation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3310994B2 (en) *	1991-07-03	2002-08-05	電気化学工業株式会社	Allergy treatment
US5633003A (en) *	1994-03-31	1997-05-27	Cantor; Jerome O.	Use of intratracheally administered hyaluronic acid to ameliorate emphysema
CA2332455C (en) *	1998-06-01	2012-08-14	Chiron Corporation	Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
EP1292314A2 (en) *	2000-05-23	2003-03-19	The Trustees of Columbia University in the City of New York	Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
AU2002315330A1 (en) *	2001-06-15	2003-01-02	Exhale Therapeutics, Inc.	Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid

2002
- 2002-11-28 FR FR0214979A patent/FR2847818B1/en not_active Expired - Lifetime
2003
- 2003-11-27 AU AU2003294100A patent/AU2003294100A1/en not_active Abandoned
- 2003-11-27 WO PCT/FR2003/003507 patent/WO2004050187A1/en not_active Ceased

Also Published As

Publication number	Publication date
FR2847818A1 (en)	2004-06-04
FR2847818B1 (en)	2008-04-04
AU2003294100A8 (en)	2004-06-23
WO2004050187A1 (en)	2004-06-17

Similar Documents

Publication	Publication Date	Title
AU2003291992A1 (en)	2004-05-25	Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003279338A1 (en)	2004-05-25	Phenethanolamine derivatives for the treatment of respiratory diseases
HUS1400011I1 (en)	2022-02-28	Novel medicaments for the treatment of chronic obstructive pulmonary diseases
SI1556342T1 (en)	2008-08-31	Phenethanolamine derivative for the treatment of respiratory diseases
AU2003285091A1 (en)	2004-06-07	Interferon antagonists useful for the treatment of interferon related diseases
AU2003210428A1 (en)	2003-09-09	Phenethanolamine derivatives for treatment of respiratory diseases
AU2003286567A1 (en)	2004-05-13	Methods for the treatment of skin disorders
PT1656346E (en)	2009-05-20	1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
IL181049A0 (en)	2007-07-04	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL179906A0 (en)	2007-05-15	Novel hydantoin derivatives for the treatment of obstructive airway diseases
SI1530466T1 (en)	2015-03-31	Use of Nintedanib for the treatment of lung fibrosis
AU2003286728A1 (en)	2004-06-07	Compounds for the treatment of metabolic disorders
AUPS017702A0 (en)	2002-02-14	Methods and compositions for the treatment of asthma and related disorders
AU2003294100A1 (en)	2004-06-23	Use of hyaluronic acid for respiratory disorders or the upper airways
IL163871A0 (en)	2005-12-18	Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
AU2003205898A1 (en)	2003-09-04	Combination therapy for respiratory disorders
AU2003289652A1 (en)	2004-07-09	The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
HRP20041160A2 (en)	2005-08-31	Novel combination for the treatment of airway disorders
AU2003269257A1 (en)	2004-05-04	Use of cap-1 for the therapy of asthma
AU2003273856A1 (en)	2004-04-19	Vr1 antagonists for the treatment of urological disorders
AU2002315330A1 (en)	2003-01-02	Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
AU2003278420A1 (en)	2004-05-25	Process for the preparation of ganciclovir
HRP20041159A2 (en)	2005-08-31	Combination for the treatment of airway disorders
GB0201025D0 (en)	2002-03-06	The treatment of degenerative diseases
EP1642589B8 (en)	2012-10-03	Preventives/remedies for snore or respiratory disturbances during sleep

Legal Events

Date	Code	Title	Description
2005-08-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2005-09-01	TH	Corrigenda	Free format text: IN VOL 18, NO 29, PAGE(S) 7783 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.), APPLICATION NO. 2003294100, UNDER INID (71) CORRECT THE NAME TO READ INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.)